Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Clin Genitourin Cancer ; 17(5): e1054-e1059, 2019 10.
Article in English | MEDLINE | ID: mdl-31303559

ABSTRACT

BACKGROUND: We tested for associations between socioeconomic status (SES) and adverse prostate cancer pathology in a population of African American (AA) men treated with radical prostatectomy (RP). PATIENTS AND METHODS: We retrospectively reviewed data from 2 institutions for AA men who underwent RP between 2010 and 2015. Household incomes were estimated using census tract data, and patients were stratified into income groups relative to the study population median. Pathologic outcomes after RP were assessed, including the postsurgical Cancer of the Prostate Risk Assessment (CAPRA-S) score and a definition of adverse pathology (stage ≥ pT3, Gleason score ≥ 4+3, or positive lymph nodes), and compared between income groups. RESULTS: We analyzed data of 347 AA men. Median household income was $37,954. Low-SES men had significantly higher prostate-specific antigen values (mean 10.2 vs. 7.3; P < .01) and CAPRA-S scores (mean 3.4 vs. 2.5; P < .01), more advanced pathologic stage (T3-T4 31.8% vs. 21.5%; P = .03), and higher rates of seminal vesicle invasion (17.3% vs. 8.2%; P < .01), positive surgical margins (35.3% vs. 22.1%; P < .01), and adverse pathology (41.4% vs. 30.1%; P = .03). Linear and logistic regression showed significant inverse associations of SES with CAPRA-S score (P < .01) and adverse pathology (P = .03). CONCLUSION: In a population of AA men who underwent RP, we observed an independent association of low SES with advanced stage or aggressive prostate cancer. By including only patients in a single racial demographic group, we eliminated the potential confounding effect of race on the association between SES and prostate cancer risk. These findings suggest that impoverished populations might benefit from more intensive screening and early, aggressive treatment of prostatic malignancies.


Subject(s)
Prostatectomy/methods , Prostatic Neoplasms/surgery , Black or African American/statistics & numerical data , Aged , Humans , Logistic Models , Male , Margins of Excision , Middle Aged , Prostate-Specific Antigen/metabolism , Prostatic Neoplasms/ethnology , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Retrospective Studies , Risk Assessment , Social Class , Survival Analysis , White People/statistics & numerical data
2.
Urology ; 113: e9-e10, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29288787

ABSTRACT

Although iatrogenic ureteral injuries are rare, they have potentially devastating consequences for both patients and physicians, and their management remains challenging. We report a case of a 51-year-old morbidly obese (body mass index = 63) woman who suffered an iatrogenic 15-cm right ureteral avulsion during hysteroscopic biopsy. Preoperative antegrade and retrograde pyelograms demonstrated no true renal pelvis and a 3-cm blind-ending distal ureteral stump. The patient underwent a right robotic downward nephropexy, psoas hitch, lower pole calycostomy, and 11-cm appendiceal interposition. At 6 months postoperatively, renal scan demonstrated stable right renal function with no evidence of obstruction.


Subject(s)
Hysteroscopy/adverse effects , Obesity, Morbid , Ureter/injuries , Ureteral Diseases/surgery , Urologic Surgical Procedures/methods , Anastomosis, Surgical/methods , Appendix/surgery , Biopsy/adverse effects , Biopsy/methods , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Hysteroscopy/methods , Iatrogenic Disease , Injury Severity Score , Middle Aged , Nephrotomy/methods , Psoas Muscles/surgery , Rare Diseases , Risk Assessment , Treatment Outcome , Ureter/surgery , Ureteral Diseases/diagnostic imaging , Ureteral Diseases/etiology , Urography/methods , Uterine Hemorrhage/diagnosis , Uterine Hemorrhage/etiology
3.
Urology ; 100: 169-174, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27639788

ABSTRACT

OBJECTIVE: To assess life expectancy and biopsy outcomes in men undergoing prostate biopsy at an academic medical center. METHODS: We analyzed men who underwent prostate biopsy at our medical center between July 2012 and June 2014. Long-term other-cause mortality risk was determined using survival tables. Indications for biopsy and biopsy outcomes were assessed, and compared among men with varying mortality risks. RESULTS: A total of 417 men underwent prostate biopsy, in whom 14-year other-cause mortality risk ranged from 9% to 74%. One hundred ninety-three men (46.3%) were considered low-mortality risk (<40% risk of 14-year mortality), 131 (31.4%) intermediate risk (41%-55% 14-year mortality), and 93 (22.3%) high risk (>55% 14-year mortality). Of the 417 patients who underwent biopsy, 149 (35.7%) were found to have prostate cancer. There was no significant difference in the rate of positive biopsies (P = .72), distribution of Gleason scores (P = .60), or percentage of positive biopsy cores (P = .74) between mortality risk groups. However, by UCSF Cancer of the Prostate Risk Assessment score, there was significant trend toward higher-risk prostate cancer in men with intermediate and high-mortality risk (P = .04). CONCLUSION: In this analysis, a large number of men with limited life expectancies underwent prostate biopsy. The majority of these men had negative biopsies or low-risk cancers, suggesting that they were unlikely to benefit from biopsy. To avoid potentially unnecessary prostate biopsies, the practitioner must give serious consideration to a patient's age and medical comorbidities before making a recommendation as to whether biopsy should be performed.


Subject(s)
Life Expectancy , Prostatic Neoplasms/complications , Prostatic Neoplasms/mortality , Academic Medical Centers , Age Factors , Aged , Biopsy , Cohort Studies , Humans , Male , Middle Aged , Neoplasm Grading , Patient Selection , Predictive Value of Tests , Prostatic Neoplasms/pathology , Risk Assessment , Survival Rate
4.
Am J Obstet Gynecol ; 214(5): 566-71, 2016 05.
Article in English | MEDLINE | ID: mdl-26519785

ABSTRACT

Iatrogenic ureteral injuries, more than half of which occur during gynecologic surgery, may have devastating consequences for both patients and physicians. Gynecologists have employed various techniques such as cystoscopy, ureteral stents, and lighted ureteral stents to prevent ureteral injuries. The emergence and increasing prevalence of robotic surgery necessitates that we not only reevaluate the utility of these techniques, but also develop new ones specific for the robotic modality. In the robotic setting, the surgeon lacks tactile feedback and must rely primarily on visual cues. The use of intraureteral indocyanine green and subsequent visualization under near-infrared fluorescence appears to be a promising technique to primarily and secondarily prevent ureteral injuries during robotic gynecologic surgery.


Subject(s)
Fluorescence , Gynecologic Surgical Procedures , Iatrogenic Disease/prevention & control , Intraoperative Care , Robotic Surgical Procedures , Ureter/diagnostic imaging , Coloring Agents , Cystoscopy , Female , Humans , Indocyanine Green , Intraoperative Complications/prevention & control , Preoperative Care , Stents , Ureter/injuries
SELECTION OF CITATIONS
SEARCH DETAIL